SSG
TARO

Summit Securities Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Summit Securities Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100
Closed -$15K – 759
2014
Q3 		$15K Buy
+100
New +$15.1K ﹤0.01% 513

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Summit Securities Group's TARO Position: Q4 2014 in Review

Summit Securities Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2014, closing a stake of 100 shares — an estimated $15K sold.

Summit Securities Group first reported a position in TARO in Q3 2014 and held it in 1 quarter. The position peaked at $15K in Q3 2014. 89 funds tracked by Wall St. Rank hold TARO as of Q4 2014.

  • Summit Securities Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2014 after selling out during the quarter.
  • Summit Securities Group sold 100 Taro Pharmaceutical Industries Ltd. shares in Q4 2014, an estimated $15K.
  • Summit Securities Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 1 quarter.
  • Summit Securities Group's Taro Pharmaceutical Industries Ltd. position peaked at $15K in Q3 2014.
  • 89 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2014.

Based on Summit Securities Group's 13F filing for Q4 2014, filed 5 Feb 2015.